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Incubation of membranes of human erythrocytes and platelets but not of human neutrophils with [32P]NAD 
leads to covalent modification of various membrane proteins and of added albumin. In membranes of all 
three cell types, pertussis toxin (PT), in the presence of NAD, specifically labelled a 40 kDa peptide, i.e. 
the a-subunit of a guanine nucleotide-binding protein. This effect of PT was slightly reduced by NADP, 
whereas modification of other membrane proteins and of albumin was largely suppressed, independent of 
whether PT was present or not. Labelling of cytosolic proteins in the presence of NAD was marginal; only 
in neutrophil cytosol, PT modified a 40 kDa peptide. Membranes of erythrocytes and platelets exhibited 
NAD-degrading activity, which was inhibited by NADP. The data suggest a high substrate specificity of 
PT for NAD. Inhibition of endogenous enzymes by NADP may prove useful for the evaluation of PT sub- 
strates. 
Pertussis toxin; ADP-ribosylation; Guanine nucleotide-binding protein; NADP 
1. INTRODUCTION 
PT causes covalent modification of peptides of 
about 40 kDa in membranes of almost all 
eukaryotic cell types studied including PMNs, 
RBCs and platelets, presumably by catalyzing 
ADP-ribosylation of these peptides with NAD be- 
ing used as a substrate [11. The peptides modified 
represent he a-subunits of N-proteins, which are 
involved in signal transduction across plasma 
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membranes by acting as transducers between cell 
surface receptors and intracellular messenger- 
generating enzymes [2] or ion channels [3-61. In 
membrane preparations from most tissues in- 
cluding membranes from RBCs and platelets, the 
PT substrate is most likely identical with the LY- 
subunit of an N-protein termed Ni, which func- 
tionally couples inhibitory receptors to adenylyl 
cyclase [7,8]. In PMN membranes, the main target 
of PT appears to be the a-subunit of a cell type 
specific N-protein (NPMN [9, IO]), which confers ac- 
tivation of the receptors for chemotactic factors 
(e.g. formylated peptides, leukotriene B and 
platelet-activating factor) to various enzymes in- 
cluding phospholipase C [ 1 I] and NADPH oxidase 
[12]. In many tissues, incubation of membrane 
preparations with [32P]NAD leads to incorpora- 
tion of radioactivity into a number of peptides. 
This endogenous activity of membranes blunts the 
effect of added toxin. Longabaugh et al. [13] 
recently reported that the efficiency of CT to 
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ADP-ribosyiate the stimuiatory N-protein of the 
adenyiyi cyciase complex (N,) in liver and heart 
membranes was improved by NADP, which siow- 
ed down the degradation of NAD in the reaction 
mixture but did not compete with NAD for CT- 
catalyzed ADP-ribosyiation of Ns. Using various 
human blood ceils, we provide evidence that in the 
presence of NAD, endogenous modification of 
membrane proteins but not of cytosolic proteins is 
efficiently suppressed by NADP, whereas PT- 
catalyzed modification of N-protein cu-subunits i  
only slightly inhibited by NADP at high concen- 
trations. 
2. MATERIALS AND METHODS 
Outdated human erythrocytes, platelet-rich 
plasma and buffy coat (as a source for PMNs) 
were provided by the local blood bank. PT was a 
generous gift from Dr M. Yajima, Kyoto, Japan. 
NADP was from Boehringer (Mannheim). Sources 
of other materials and reagents have been de- 
scribed [14]. 
Plasma membranes and cytosoi of PMNs were 
prepared as in [ 121. For complete removal of mem- 
branes, the cytosol was recentrifuged for 2 h at 
200000 x g. Membranes from RBCs were prepared 
as in [ 151. For the preparation of cytosol, isolated 
RBCs were repeatedly frozen in liquid nitrogen. 
After centrifugation at 2~~ x g for 2 h, the 
supernatant fluid was applied to a DEAE-Sephacei 
column. Hemoglobin, which did not bind to the 
resin, was removed by extensive washing. Bound 
proteins were eluted by 1 M NaCl and concen- 
trated by ultrafiltration, using PM 10 filters 
(Amicon, Witten, FRG); this preparation is refer- 
red to as ‘cytosoi’. Platelets were isolated as 
described 1161 and disrupted by repeated freezing 
in liquid nitrogen. Particulate and soluble frac- 
tions were separated by 200000 x g centrifugation 
(2 h) and constitute the membraneous and 
cytosolic preparations, respectively. 
PT-catalyzed [32P]ADP-ribosyiation was per- 
formed as in il7]. Preactivated PT was diluted 
with BSA-containing buffer to a final concentra- 
tion of 1.7 pg/ml. Control samples received diiu- 
tion buffer without the toxin. BSA was 1Opg per 
assay tube (assay volume 60 pl), and the final NAD 
concentration was 1 ,,xM with l-2 &i [32P]NAD 
per assay tube. Incubation was for 30 min at 30°C. 
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Variations in the reaction mixture from the basic 
protocol are given in the figure legends. Prior to 
SDS-PAGE, proteins were precipitated with 
acetone and the pellets subsequently washed with 
t~chioroacetic acid and chloroform. SDS-PAGE 
was performed according to Laemmii [ig] as 
described elsewhere [141. TLC of nucieotides was 
performed on polyethyieneimine sheets (Schieicher 
and Schiiii, Dassei, FRG), using 0.1 M LiCi10.5 M 
formic acid as the mobile phase [ 191. 
Autoradiography of dried poiyacrylamide gels and 
TLC sheets was performed as described [14]. In 
some experiments, radiolabeiied bands of dried 
gels were cut out and the radioactivity determined 
by liquid scintillation counting. [Q-~‘P]ATP was 
synthesized according to Johnson and Waiseth [20] 
and [32P]NAD as described by Cassei and Pfeuffer 
[ 191. Protein was assayed according to Lowry et al. 
1211, using BSA as a standard. Results of the ex- 
periments hown were typical for those obtained in 
at least two repeated experiments. 
3. RESULTS 
In the absence of NADP and PT, there was 
significant labelling of a number of proteins in 
PMN RBC platelet 
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Fig.1. Influence of NADP on endogenous and PT- 
catalyzed labelling of membrane proteins incubated with 
t3*P]NAD. Membranes of the indicated cell types were 
incubated with (32P]NAD in the absence and presence of 
NADP (0.5 mM) and PT. Different amounts of 
membrane protein were chosen for each cell type to 
achieve comparable incorporation of radioactivity into 
the peptides of 40 kDa in the presence of PT (PMNs, 
IOpg protein; RBCs, 15Opg; platelets, 1OOyg). Shown 
are autoradiographs of SDS-polyacrylamide gels 
(12.5%). DF, dye front. 
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platelet and RBC membranes but not in PMN 
membranes incubated with [32P]NAD (fig.1). The 
labelled peptides included one of 67 kDa, most 
likely representing BSA, a constituent of the reac- 
tion mixture and known to be labelled in the 
presence of [32P]NAD [22]. Endogenous labelling 
of proteins was strongest in RBC membranes and 
included peptides with apparent molecular masses 
larger than 94 kDa (among them presumably spec- 
trin) and a peptide of 39 kDa. The endogenous ac- 
tivity of platelet and RBC membranes was 
efficiently inhibited by NADP (0.5 mM). In all 
membrane preparations, PT specifically radio- 
labelled peptides of about 40 kDa, which are 
believed to represent he a-subunits of N-proteins. 
This activity of PT was inhibited very little by 
NADP. Fig.2 shows a concentration-response 
curve for NADP. In membranes of platelets and 
RBCs, NADP at concentrations above 30 pM in- 
hibited labelling of various peptides including 
those of large apparent molecular masses 
(>94 kDa) and peptides of 67 kDa; in addition, 
labelling of peptides of small apparent molecular 
masses (~20 kDa) and a peptide of 39 kDa was 
PMN 
NADP (mM) 0 0.03 0.3 
0.01 0.l 1.0 
reduced by NADP in RBC membranes; only at 
concentrations of NADP above 0.3 mM was incor- 
poration into a-subunits slightly reduced in all 
tested tissues. When increasing amounts of mem- 
brane proteins of platelets and RBCs were in- 
cubated with PT and [32P]NAD but without 
NADP, increased incorporation of radioactivity 
into the a-subunits and other peptides including 
BSA, which was present at a constant concentra- 
tion, and into material that moved with the dye 
front was observed (fig.3). In contrast, only the in- 
corporation into a-subunits paralleled the amount 
of PMN membrane protein. Labelling of peptides 
other than the a-subunits was efficiently suppress- 
ed by NADP. On the other hand, labelling of (Y- 
subunits was only moderately reduced in all tissues 
and at all amounts of membrane protein 
employed. 
In the soluble fraction of RBCs, very little en- 
dogenous activity was detected (fig.4). In contrast, 
peptides of 39 and 67 kDa were labelled in the 
absence of PT in cytosol of PMNs and platelets, 
respectively. The endogenous activity was little af- 
fected by NADP at 0.5 mM. Only in PMN cytosol 
0.01 0.1 113 0.01 0.1 1.0 
Fig.2. NADP-induced inhibition of covalent modification of membrane proteins incubated with [32P]NAD. 
Experimental conditions were as described for fig. 1, with the exception that all samples received PT and NADP at the 
indicated concentrations. 
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Fig.3. Influence of the amount of membrane protein on 
endogenous and PT-catalyzed protein modification in 
the presence of [3ZP]NAD. Particulate fractions of 
PMNs, RBCs or platelets were incubated with PT and 
1 FM [“PINAD (about 2 pCi per assay tube) in the 
absence or presence of NADP (0.5 mM) and subjected 
to SDS-PAGE. Labelled peptides were identified by 
autoradiography, excised, and the incorporated activity 
determined. The amounts of protein per assay tube were 
1.3, 2.5, 5 and 1Opg for PMN membranes, 19, 38, 75 
and 15Opg for RBC membranes, and 12.5, 25, 50 and 
1OOpg for platelet membranes (bars from left to right 
for the indicated molecular masses). Total bars and 
dotted parts of bars indicate incorporation of 
radioactivity in the absence and presence of NADP, 
respectively. In PMN membranes, the activity 
incorporated into regions other than the 40 kDa region 
and the dye front was not higher than background 
activity. 
was a PT substrate of 40 kDa clearly detectable. 
By two-dimensional gel electrophoresis and tryptic 
peptide maps, this peptide was identical with one 
of the two PT substrates of PMN plasma mem- 
branes, which have indistinguishable apparent 
molecular masses but differ in charge (unpublish- 
ed); this cytosolic substrate is, therefore, likely to 
represent the a-subunit of an N-protein. PT slight- 
ly stimulated radiolabelling of peptides of 39 and 
67 kDa in PMN and platelet cytosol, respectively. 
PMN RBC platelet 
NADP - - ++ - - + + --++ 
PT - + -+ - + - + - + -+ 
Fig.4. Influence of NADP on endogenous and PT- 
catalyzed covalent modification of cytosolic proteins 
incubated with [3ZP]NAD. Experimental conditions as in 
fig.1. The amounts of protein employed were 9 pg 
(PMNs), 11 pg (RBCs) and 12 gg (platelets). 
The significance of this PT effect is not clear. In 
PMN cytosol, the PT-induced incorporation of 
radioactivity into the peptide of 39 kDa was not or 
marginally stimulated by the fly complex of N- 
proteins, whereas the incorporation of radioactivi- 
ty into the 40 kDa peptide was increased more than 
IO-fold (not shown). This indicates that the peptide 
of 39 kDa does not interact with the,& complex of 
N-proteins and, therefore, is not related to an N- 
protein a-subunit. 
Incubation of particulate and soluble fractions 
of the three cell types with [32P]NAD and PT 
revealed that membranes of erythrocytes and to a 
lesser extent membranes of platelets contain NAD- 
degrading enzymes with the major degradation 
product being ADP-ribose (fig.5); another 
degradation product exhibited the mobility of Pi. 
Degradation of NAD was not detectable in PMN 
membranes and in soluble fractions of the three 
tested cell types. The NAD degradation in mem- 
branes of RBCs and platelets was inhibited by 
NADP at 0.5 mM. At NADP concentrations lower 
than 0.1 mM, degradation of NAD was still detec- 
table although reduced in both tissues when pro- 
tein amounts of 15Opg (RBCs) and 100 pug 
(platelets) were employed (not shown). 
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Fig.5. Degradation of [32P]NAD by soluble and particulate fractions of human blood cells in the absence and presence 
of NADP. The amounts of protein per assay tube were as those in figs 1,4. The various preparations were incubated 
with PT and [32P]NAD as described in section 2; NADP was 0.5 mM. The incubation was stopped by the addition of 
15 pl of 100% trichloroacetic acid. After centrifugation (10000 x g, 30 min at 4”C), 2 ,ul of the supernatant were diluted 
25fold with 50 mM imidazole buffer (pH 7.0). 1~1 of the diluted supernatants was applied to a TLC sheet. Shown 
are autoradiographs of developed TLC sheets. PT, cytosolic fractions of all tested tissues and PMN membranes did 
not possess NAD-degrading activity to an extent that was detectable by TLC. Non-radioactive nucleotides were used 
as markers and localized by fluorescence. The mobility of phosphate was assumed to be identical with that of the 
labelled egradation product of boiled [Y-~~P]ATP. The fast moving radioactive compound close to the solvent front 
was not attributable to the markers hown, NADH or NADP. S, soluble fraction; P, particulate fraction. 
4. DISCUSSION 
The reported data indicate that membrane 
preparations of RBCs and platelets but not of 
PMNs contain an activity responsible for covalent 
modification of various peptides in the presence of 
NAD. This endogenous activity blunts the effect of 
exogenous ADP-ribosyltransferases uch as PT or 
CT. This is particularly obvious in membranes of 
RBCs, where in the presence of [32P]NAD, a 
number of peptides including one of 39 kDa incor- 
porate activity independently of PT. In all cell 
types tested, the toxin specifically modifies pep- 
tides with an apparent molecular mass of 40 kDa, 
i.e. the a-subunits of N-proteins. 
The coincidence of the inhibitory effect of 
NADP on protein modification in particulate frac- 
tions incubated with NAD on the one hand, and of 
the inhibitory effect of NADP on NAD degrada- 
tion on the other, suggest a relationship between 
the two events. We assume that endogenous NAD 
glycohydrolases are, at least in part, responsible 
for NAD degradation, as the major NAD degrada- 
tion product in RBCs and platelets appears to be 
ADP-ribose. In analogy to the bacterial toxins, 
these enzymes may also catalyze ADP-ribosylation 
of proteins by an inherent ADP-ribosyltransferase 
activity; alternatively, ADP-ribosylation may oc- 
cur nonenzymatically once ADP-ribose has been 
formed [22]. The endogenous NAD-degrading en- 
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zymes probably utilize NADP besides NAD, as has 
been reported for microsomal NAD glyco- 
hydrolases of Ehrlich ascites cells [23]. The ac- 
cumulation of phosphate in the NAD-degrading 
membranes is difficult to explain. The finding that 
NADP, which presumably inhibits enzymatic 
breakdown of NAD, also inhibits phosphate ac- 
cumulation is consistent with the idea that 
phosphate is derived from an enzymatically form- 
ed NAD-degradation product. 
The degradation of NAD to ADP-ribose and 
nicotinamide cannot be accounted for by the NAD 
glycohydrolase activity of PT [24], as there was no 
detectable degradation of NAD by PT in the 
absence or presence of PMN membranes or soluble 
fractions. In contrast to the endogenous enzymes, 
the specificity of PT for NAD as its substrate is ex- 
ceptionally high and its ability to ADP-ribosylate 
a-subunits is little reduced by a several hundred- 
fold excess of NADP over NAD. The inhibition of 
PT-catalyzed ADP-ribosylation, which amounted 
to up to 27% in plasma membranes of PMNs, may 
be due either to NAD, contaminating the commer- 
cially available NADP, or to the fact that NADP 
is a low-affinity substrate for PT. 
The endogenous activity that modifies proteins 
in the presence of NAD differs from tissue to tissue 
and is much higher in particulate than soluble frac- 
tions. The enzymes responsible for this activity ap- 
pear to be very active in membranes of RBCs and 
less active in a crude particulate fraction of 
platelets; they are not detectable in plasma mem- 
branes from PMNs. Whether these differences are 
due to differences in enzyme activity or substrate 
availability is not known, although the latter 
assumption is less likely as labelling of the ex- 
ogenous substrate, BSA, increased with the 
amount of membrane protein employed. In any 
case, the use of NADP as a constituent in assays 
designed for identification and characterization of 
PT substrates, i.e. the a-subunits of N-proteins, 
improves the specific signal considerably. Besides 
its usefulness for the autoradiographic evaluation 
of SDS-polyacrylamide gels, the use of NADP will 
most likely also improve the specificity of the filter 
assay method [25] and the polyethylene glycol 
precipitation method [26] for purified PT 
substrates by inhibiting PT-independent labelling 
of contaminating proteins and of exogenous pro- 
teins that are introduced into the reaction mixture. 
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Finally, it may open up the possibility of using 
assays based on protein adsorption or protein 
precipitation for qualitative and quantitative 
evaluation of PT substrates in membranes and 
crude membranous extracts. 
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